Profile data is unavailable for this security.
About the company
Ziccum AB is a Sweden-based pharmaceutical company that is mainly engaged in developing vaccines. Ziccum develops new thermostable versions of vaccines and biologics for licensing to vaccine suppliers, developers, manufacturers and CDMOs in the global pharmaceutical industry. Ziccum's patented drying technology, LaminarPace, is unique. It can dry-formulate temperature-sensitive vaccine materials at room temperature with high yield and low waste. These robust, thermostable dry powders can be stored and transported worldwide without the need for a cold chain or freezing. The company conducts its business by entering into strategic collaborations with major pharmaceutical companies and offering licenses to the Company's patented technology.
- Revenue in SEK (TTM)5.56m
- Net income in SEK-23.18m
- Incorporated2018
- Employees10.00
- LocationZiccum ABScheelevagen 15LUND 223 63SwedenSWE
- Phone+46 84429586
- Websitehttps://ziccum.com/